One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: Differing efficacy in previously treated and untreated patients

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 6, 1996, Pages 1015-1019

  Moshkowitz, M ^a,b   Konikoff, F M ^a   Peled, Y ^a   Brill, S ^a   Hallak, A ^a   Tiomny, E ^a   Santo, M ^a   Bujanover, Y ^a   Gilat, T ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; OMEPRAZOLE; TINIDAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BREATH ANALYSIS; DRUG EFFICACY; FEMALE; GASTRITIS; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; STOMACH ULCER;

EID: 0029850832     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.96268000.x     Document Type: Article

References (19)

1. Graham DY. Treatment of peptic ulcers caused by Helicobacter pylori. N Engl J Med 1993; 328: 349-50.
2. National Institute of Health. Consensus conference. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272; 65-9.
3. Chiba N, Rao BV, Rademaker JW, Hunt RW. Meta-analysis of the efficacy of antibiotic therapy in eradicating H. pylori. Am J Gastroenterol 1992; 87: 1716-27.
4. Noach LA, Bertola MA, Schwartz MP, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: an evaluation of various therapeutic trials. Eur J Gastroenterol Hepatol 1994; 6: 585-92.
5. Bazzoli F, Zagari RM, Fossi S, et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 773-7.
6. Labenz J, Stolte M, Ruhl GH, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroentero Hepatol 1995; 7: 9-11.
7. Yousfi MM, El-Zimaity HMT, Al-Assi MT, Cole RA, Genta DY, Graham DY. Metronidazole, omeprazole and clarythromicm: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 209-12.
8. Detenre M, De Koster E, Van Gossum M, De Reuck M, Jonas C. Omeprazole based therapies for eradication of Helicobacter pylori Gut 1995; 37 (Suppl. 1): A90(Abstract).
9. Goddard A, Logan R. One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995; 7: 1-3.
10. 14C-urea breath test - a simple, noninvasive method for the detection of Helicobacter pylori infection. Isr J Med Sci 1993; 29: 94-7.
11. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of H. pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
12. Van Zwet AA, Thys JC, Oom JAJ, Hoogeveen J, Duringshoff BL. Failure to eradicate H. pylori in patients with metronidazole resistant strains. Eur J Gastroenterol Hepatol 1993; 5: 185-6.
13. Nilius M, Strohle A, Bode G, Malfertheiner P. Coccoid like forms (CLF) of Helicobacter pylori-enzyme activity and antigenicity. Int J Med Microbiol Virol Parasitol Infect Dis 1993; 280: 259-72.
14. Berger SA, Gorea A, Moshkowitz M, Santo M, Gilat T. Effect of inoculum size on antimicrobial suceptibility of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1993; 12(10): 782-3.
15. Logan RPH, Gummett PA, Schaufelberger HD, et al. Eradication of Helicobacter pylori with clarythromycin and omeprazole. Gut 1994; 35: 323-6.
16. Cutler AF, Havstad S, Ma CK, Blaser M, Perez-Perez GI, Schubert TT. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995; 109: 136-41.
17. Moayyedi P, Axon ATR. Patient factors that predict failure of omeprazole, clarithromycin and tinidazole (OCT) to eradicate Helicobacter pylori (H. pylori) Gut 1995; 37(Suppl. 1): A46(Abstract).
18. Cutler AF, Schubert TT. Patient factors affecting H. pylori eradication with triple therapy. Am J Gastroenterol 1993; 88: 505-9.
19. Moshkowitz M, Konikoff FM, Peled Y, et al. High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. Gut 1995; 36: 845-7.